NTLA
Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.NTLA

11.12USD
-3.05%
Oct 28, 2026
NTLA overview ready
Price
Loading price history…

Price Action

Early

Key Financials

Market Cap
$1.6B
Avg Volume (60D)
5.6M
60 sessions
Revenue Growth YoY
+16.9%
FY2025 vs FY2024
Operating Margin
-711.7%
Trailing twelve months
Free Cash Flow Yield
-22.4%
P/E
N/M
Market metrics as of Jul 22, 2026
Financial results for the period ended Jun 30, 2026
Filed balance-sheet data as of Jun 30, 2026

Fundamentals & Valuation

No valuation has been published for this company yet.

What changed

  • NTLA rose 9.1% in one session
    NTLA closed +9.1% while the broad market was close to flat (+0.6%).
    2026-10-27

Company Research

Research coverage for this company is in progress.

Economic classification

Loading the economic classification…

Business & Markets

No company profile has been published for this ticker yet.